Abacus Planning Group’s Pacific Biosciences PACB Stock Holding History

Abacus Planning Group’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$121K	Hold	51,238	–	–	0.01%	258
2026 Q2	$86.1K	Hold	51,238	–	–	0.01%	256
2026 Q1	$67.6K	Sell	51,238 -48,762	-49%	-$87.2K	0.01%	262
2025 Q4	$187K	Hold	100,000	–	–	0.02%	254
2025 Q3	$128K	Hold	100,000	–	–	0.02%	249
2025 Q2	$124K	Hold	100,000	–	–	0.02%	237
2025 Q1	$118K	Hold	100,000	–	–	0.02%	223
2024 Q4	$183K	Hold	100,000	–	–	0.03%	209
2024 Q3	$170K	Hold	100,000	–	–	0.03%	205
2024 Q2	$137K	Hold	100,000	–	–	0.03%	203
2024 Q1	$375K	Hold	100,000	–	–	0.07%	129
2023 Q4	$981K	Hold	100,000	–	–	0.21%	71
2023 Q3	$835K	Hold	100,000	–	–	0.2%	77
2023 Q2	$1.33M	Sell	100,000 -20,000	-17%	-$243K	0.32%	45
2023 Q1	$1.39M	Hold	120,000	–	–	0.36%	41
2022 Q4	$982K	Sell	120,000 -20,000	-14%	-$172K	0.27%	59
2022 Q3	$813K	Hold	140,000	–	–	0.25%	64
2022 Q2	$619K	Hold	140,000	–	–	0.18%	85
2022 Q1	$1.27M	Sell	140,000 -15,000	-10%	-$173K	0.34%	51
2021 Q4	$3.17M	Sell	155,000 -25,000	-14%	-$603K	0.85%	22
2021 Q3	$4.6M	Hold	180,000	–	–	1.46%	13
2021 Q2	$6.3M	Hold	180,000	–	–	1.92%	11
2021 Q1	$6M	Sell	180,000 -220,000	-55%	-$7.7M	1.92%	11
2020 Q4	$10.4M	Sell	400,000 -302,937	-43%	-$5.15M	3.2%	8
2020 Q3	$6.94M	Buy	+702,937	New	+$4.05M	2.53%	9

Other funds holding PACB

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Advisornet Financial Minnetonka, Minnesota $2.21B AUM 14.38% 1-Year Est. Return

Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

HUB Investment Partners Austin, Texas $5.8B AUM 24.38% 1-Year Est. Return

Evolution Wealth Advisors Aventura, Florida $960M AUM 20.9% 1-Year Est. Return

Abacus Planning Group's PACB Position: Q3 2026 in Review

Abacus Planning Group held its Pacific Biosciences (PACB) position steady in Q3 2026 at 51,238 shares worth $121K. The position accounts for 0.01% of the portfolio, ranked #258.

Abacus Planning Group first reported a position in PACB in Q3 2020 and has held it in 25 quarters since. The position peaked at $10.4M in Q4 2020. 46 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

Abacus Planning Group held 51,238 shares of Pacific Biosciences worth $121K as of Q3 2026.
Abacus Planning Group left its Pacific Biosciences share count unchanged in Q3 2026.
Pacific Biosciences made up 0.01% of Abacus Planning Group's portfolio in Q3 2026, its #258 holding.
Abacus Planning Group first reported a position in Pacific Biosciences in Q3 2020 and has held it in 25 quarters since.
Abacus Planning Group's Pacific Biosciences position peaked at $10.4M in Q4 2020.
46 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Abacus Planning Group's 13F filing for Q3 2026, filed 2 Nov 2026.